Castle Biosciences (CSTL) Non Operating Income (2018 - 2026)

Castle Biosciences (CSTL) posted Non Operating Income of -$439000.0 for Q1 2026, down 557.29% sequentially from $96000.0 in Q4 2025.

Castle Biosciences (CSTL) Non Operating Income (2018 - 2026) Analysis & Trends

Castle Biosciences (CSTL) has 4 years of Non Operating Income data on file, last reported at -$439000.0 in Q1 2026.

Quarterly Non Operating Income changed N/A year-over-year to -$439000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$295000.0 (changed N/A YoY) and the FY2025 annual result came in at $144000.0, changed N/A from the prior year.
Non Operating Income declined to -$439000.0 in Q1 2026 per CSTL's latest filing, from $96000.0 in the prior quarter.
The five-year high for Non Operating Income was $96000.0 in Q4 2025, with the low at -$439000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Op. Inc. (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	1.00 Mn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	-9.00 Mn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	-73.00 Mn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	-
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	9.60 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	21.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	-4.00 Mn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	-52.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	7.33 Mn
10	Castle Biosciences	738.56 Mn	476.84 Mn	63.15 Mn	-439,000.00

Download Data